MaxWell Biosystems employee Dr. Annalisa Bucci received the Swiss OphthAWARD 2026 Best Experimental Work award in the Best Experimental Work category for her research on human retina synchronization.
Published
Signal category
Presence & Recognition
Quote
“Congratulations to Dr. Annalisa Bucci on receiving the Swiss OphthAWARD 2026!”
— MaxWell Biosystems team
Company
MaxWell Biosystems
Every Cell Has A Story To Tell. Connect to your cells and track their activity, connectivity and maturity.
- Industry
- Biotechnology Research
- Location
- Zurich, CH
- Company size
- 49 employees
Founded in September 2016 as an ETH Zürich spin-off, MaxWell Biosystems is a technology leader providing instrumentation and solutions to boost scientific research and development in neurosciences, stem cell and tissue engineering, ophthalmology, and other fields involving electrogenic cells. MaxOne (single-well) and MaxTwo (multi-well) are easy-to-use systems that equip scientists with the ability to record electrical signals of neurons in in-vitro 2D and 3D models at network, cellular, and subcellular levels. MaxWell Biosystems’ main goal is to be a trusted partner to all users and collaborators, for a greater cause, of advancing scientific breakthroughs and for achieving faster and more effective drug discovery, through our products, solutions, and expertise.
Founded 2016